• Photo by: Caitlin Abrams
    Photo by: Caitlin Abrams

    Prof. Robert Vince featured on Mpls.StPaul Magazine

    Life Saver: Robert Vince, a Minnesota superhero, creates drugs to combat diseases like AIDS and cancer.

    Read More

  • Wang Group

    Prof Wang Awarded NIH Grant

    Congratulations to Prof. Zhengqiang Wang for being awarded a new 5 year grant by NIH

    Structural studies of HIV Capsid with host factors and Capsid-targeting antivirals
    Duration: 06/15/2015—05/31/2020
    Funding Agency: NIH/NIAID
    Type: Multiple PI R01
    PI(s): Stefan Sarafianos, PhD & Zhengqiang Wang, PhD

  • Dr. Vince and More

    Research on Alzheimer's Disease by Prof Vince and Prof More Featured on C&EN News

    Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear

    Prof Swati More and Prof Robert Vince have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye. The pair have peered into the retinas of mice with their patented, microscope-based method, they hope to one day use it to identify Alzheimer’s disease in human patients years before symptoms manifest.
    Read more

  • OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg
    OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg

    Prof Chen's Research on Parkinson’s Disease featured by the University

    Drug Design for Parkinson’s Disease Starts Here

    Recently, University of Minnesota Center for Drug Design member, organic chemist and assistant professor Prof Liqiang Chen, published a paper in the Journal of Medicinal Chemistry outlining the discovery of a potent and selective protein-inhibitor. Blocking the protein, Sirtuin 2 (SIRT2), also has the potential to block a primary contributor to Parkinson’s disease from causing harm.
    Read more

Message from the Director

Robert Vince

Robert Vince, PhD

The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value  for our academic and research community.

Read the full message

Next Seminar

Kathlynn BrownKathlynn Brown, PhD
Program Director of Functional Peptide Development
SRI International
Harrisonburg, VA

Dr. Brown's research team is developing peptides that target tumors for use as delivery vehicles for drugs, nanoparticles, and toxins. They are also utilizing the peptides to develop novel immunotherapies to fight cancer. Additionally, the peptides are being utilized as molecular imaging agents for diagnosis and classification of cancers.

Date: Feb 17, 2016     Time: 10:15 - 11:15 AM      Venue: Nils Hasselmo Hall 2-101


Spotlight on Research

Alzheimer’s Disease Research

Profs Robert Vince and Swati More have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye.

Pre-Clinical Study for Cyanide Antidote

A faster acting and safer than existing options, an antidote for cyanide poisoning that works prophylactically to prevent or limit toxicity associated from exposure to cyanide has been developed.

CDD Functional Cosmetic

The Center for Drug Design has developed compounds that not only protect the skin from UV damage but also activate the enzymes which repair damaged DNA in the skin.